New York State Common Retirement Fund’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-322
| Closed | – | – | 3346 |
|
|
2024
Q2 | $0 | Sell |
322
-21,545
| -99% | – | ﹤0.01% | 3396 |
|
|
2024
Q1 | $52K | Buy |
21,867
+372
| +2% | +$885 | ﹤0.01% | 2973 |
|
|
2023
Q4 | $48K | Sell |
21,495
-121
| -0.6% | -$270 | ﹤0.01% | 3017 |
|
|
2023
Q3 | $46K | Buy |
21,616
+416
| +2% | +$885 | ﹤0.01% | 3045 |
|
|
2023
Q2 | $66K | Buy |
+21,200
| New | +$66K | ﹤0.01% | 3074 |
|
|
2022
Q3 | – | Sell |
-190
| Closed | -$1K | – | 3458 |
|
|
2022
Q2 | $1K | Sell |
190
-10,504
| -98% | -$55.3K | ﹤0.01% | 3419 |
|
|
2022
Q1 | $65K | Buy |
10,694
+45
| +0.4% | +$274 | ﹤0.01% | 3115 |
|
|
2021
Q4 | $124K | Buy |
10,649
+2,843
| +36% | +$33.1K | ﹤0.01% | 3021 |
|
|
2021
Q3 | $122K | Sell |
7,806
-3,486
| -31% | -$54.5K | ﹤0.01% | 3079 |
|
|
2021
Q2 | $211K | Buy |
11,292
+2,692
| +31% | +$50.3K | ﹤0.01% | 3024 |
|
|
2021
Q1 | $371K | Buy |
+8,600
| New | +$371K | ﹤0.01% | 2584 |
|